This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Fisher Wallace Neurostimulation & Depression Study

Sponsored by ProofPilot

About this trial

Last updated 4 years ago

Study ID

2518

Status

Active, not recruiting

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
21+ Years
All
All

Trial Timing

Ended 4 years ago

What is this trial about?

Examine the safety and effectiveness of the Fisher Wallace Cranial Electrotherapy Stimulator Device on Major Depressive Disorder using two 20-minute per day treatment sessions over eight weeks.

What are the participation requirements?

Yes

Inclusion Criteria

- Age greater than or equal to 21

- US resident

- Can receive packages to their home via UPS/Fedex/USPS

- Major Depressive Disorder

- PHQ-8 Score greater than 10 (show some signs of mild to moderate depression)

- PHQ-8 Score less than 20 (given remote study serious depressed should be excluded)

- Read/write English

- have not contemplated suicide in the past year

- not been institutionalized for mental health issues.

- not currently experiencing problems with alcohol or drug abuse

- can commit to not drinking alcohol 4 hours before bedtime for the duration of the study

- can commit to two (2) 20 minute sessions per day for 8 weeks

- has not used a brain stimulation treatment in one year

- no suspected or known history of heart disease

- no pacemaker

- not under medical supervision for other serious medical condition

- not taking opioids

- is a resident of states in which we have licensed medical professionals

Locations

Location

Status